RELATIONSHIP BETWEEN HYPOGONADISM AND SERUM TESTOSTERONE LEVELS IN CHRONIC LIVER DISEASE
DOI:
https://doi.org/10.69656/pjp.v20i3.1687Keywords:
Hypogonadism, Serum Testosterone, SHBG, CLDAbstract
Background: Men with extensive chronic liver disease usually have low levels of testosterone in the serum. This study looked at the relationship between hypogonadism and low serum testosterone levels in patients with chronic liver disease. Methods: This retrospective study was conducted at Central Park Teaching Hospital, Lahore from Jan 2022 to Jan 2024, on patients between 5 to 60 years of age. After approval from ERB and permission from the authorities, records were retrieved. Two hundred records of men with hepatic cirrhosis and verified hypogonadism were divided into alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD), while records of 150 men as control group were include in the study. Patients’ data for ‘Sex Hormone Binding Globulin (SHBG)’ and ‘total testosterone’ were collected and entered into MS Excel file. Using SPSS-22 independent Student’s t-test was applied for statistical analysis. Results: No statistically significant variations were observed (p=0.101) in the means of SHBG across two groups but there was a statistically significant (p<0.05) variation in blood serum testosterone levels between age groups. Conclusion: Hypogonadism and low levels of testosterone are strongly linked to male patients with cirrhotic liver conditions, particularly in those with ALD, while no significant impact of SHBG was found between the two groups. Significant differences were observed between patients with ALD and NAFLD in terms of testosterone levels.
Pak J Physiol 2024;20(3):53–5, DOI: https://doi.org/10.69656/pjp.v20i3.1687
Downloads
References
Saalu LC, Osinubi AA. Andropause (male menopause): valid concepts, fables, and controversies. Univ Lagos J Basic Med Sci 2022;1(1):34–7.
Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, et al. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol 2022;96(2):200–19.
Lauretta R, Sansone M, Sansone A, Romanelli F, Appetecchia M. Gender in endocrine diseases: role of sex gonadal hormones. Int J Endocrinol 2018;2018:4847376.
Rochira V. Hypogonadism in Systemic Diseases. In: Simoni M, Huhtaniemi IT, (Eds). Endocrinology of the Testis and Male Reproduction. Vol-1. Cham: Springer; 2017.p. 829.
Von-Hafe M, Borges-Canha M, Vale C, Leite AR, Sérgio Neves J, Carvalho D, et al. Nonalcoholic fatty liver disease and endocrine axes —a scoping review. Metabolites 2022;12(4):298.
Jadzic J, Cvetkovic D, Milovanovic P, Tomanovic N, Zivkovic V, Nikolic S, et al. The micro-structural analysis of lumbar vertebrae in alcoholic liver cirrhosis. Osteoporos Int 2020;31:2209–17.
Diem SJ, Greer NL, MacDonald R, McKenzie LG, Dahm P, Ercan-Fang N, et al. Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med 2020;172(2):105–18.
Keevil BG, Adaway J. Assessment of free testosterone concentration. J Steroid Biochem Mol Biol 2019;190:207–11.
Salas?Huetos A, Maghsoumi?Norouzabad L, James ER, Carrell DT, Aston KI, Jenkins TG, et al. Male adiposity, sperm parameters, and reproductive hormones: An updated systematic review and collaborative meta?analysis. Obe Rev 2021;22(1):e13082.
Heydari M, Cornide-Petronio ME, Jiménez-Castro MB, Peralta C. Data on adiponectin from 2010 to 2020: therapeutic target and prognostic factor for liver diseases. Int J Mol Sci 2020;21(15):5242.
Zhang D, Wei Y, Huang Q, Chen Y, Zeng K, Yang W, et al. Important hormones regulating lipid metabolism. Molecules 2022;27(20):7052.
Dowman JK, Hopkins LJ, Reynolds GM, Armstrong MJ, Nasiri M, Nikolaou N, et al. Loss of 5?-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice. Endocrinol 2013;154(12):4536–47.
Nikolaou N, Hodson L, Tomlinson JW. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. J Steroid Biochem Mol Biol 2021;207:105808.
Rzeszotek S, Kolasa A, Pilutin A, Misiakiewicz-Has K, Sielatycka K, Wiszniewska B. The interplay between finasteride-induced androgen imbalance, endoplasmic reticulum stress, oxidative stress, and liver disorders in paternal and filial generation. Biomedicines 2022;10(11):2725.
Zaitoun AM, Apelqvist G, Wikell C, Al?Mardini H, Bengtsson F, Record CO. Quantitative studies of testicular atrophy following portacaval shunt in rats. Hepatology 1998;28(6):1461–6.
Wang C, Swerdloff R. What to Measure: Testosterone or Free Testosterone? In: Mulhall JP, Maggi M, Trost L, (Eds). Controversies in testosterone deficiency. Cham: Springer; 2021. p. 1–13. URL: https://link.springer.com/10.1007/978-3-030-77111-9_1
Quan L, Hu L, Wang J, Yuwen B, Zhu J, Jiang S. Relationship between sex hormone-binding globulin level and blood glucose in middle-aged and elder males of Uygur ethnic group. Neuro Endocrinol Lett 2021;42(6):403–7.
Targher G, Byrne CD. From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: Is it time for a change of terminology? Hepatoma Res 2020;6:64.
Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Medical Sciences 2021;9(2):39.
Ye J, Zhai X, Yang J, Zhu Z. Association between serum testosterone levels and body composition among men 20–59 years of age. Int J Endocrinol 2021;2021:7523996.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.
